KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Goodwill & Intangibles (2016 - 2025)

Abbott Laboratories' Goodwill & Intangibles history spans 17 years, with the latest figure at $6.3 billion for Q1 2025.

  • For Q1 2025, Goodwill & Intangibles changed N/A year-over-year to $6.3 billion; the TTM value through Mar 2025 reached $6.3 billion, changed N/A, while the annual FY2024 figure was $29.7 billion, N/A changed from the prior year.
  • Goodwill & Intangibles for Q1 2025 was $6.3 billion at Abbott Laboratories, down from $29.7 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $51.3 billion in Q2 2021 and bottomed at $6.3 billion in Q1 2025.
  • The 5-year median for Goodwill & Intangibles is $23.3 billion (2021), against an average of $27.8 billion.
  • The largest YoY upside for Goodwill & Intangibles was 111.21% in 2021 against a maximum downside of 54.17% in 2021.
  • A 5-year view of Goodwill & Intangibles shows it stood at $50.9 billion in 2021, then plummeted by 34.67% to $33.3 billion in 2022, then crashed by 30.0% to $23.3 billion in 2023, then grew by 27.8% to $29.7 billion in 2024, then plummeted by 78.95% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Goodwill & Intangibles are $6.3 billion (Q1 2025), $29.7 billion (Q4 2024), and $23.3 billion (Q2 2024).